Cargando…
Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer
BACKGROUND: Adjuvant chemotherapy could reduce residual tumor cells and prevent relapse, however, not all patients are suitable for adjuvant chemotherapy. Screening appropriate patients based on molecular markers for individualized adjuvant chemotherapy is necessary. METHODS: Between June 2002 and J...
Autores principales: | Yu, Pengfei, Du, Yian, Cheng, Xiangdong, Yu, Qiming, Huang, Ling, Dong, Ruizeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198758/ https://www.ncbi.nlm.nih.gov/pubmed/25304659 http://dx.doi.org/10.1186/1477-7819-12-307 |
Ejemplares similares
-
Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study
por: Yu, Pengfei, et al.
Publicado: (2020) -
Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study
por: Yu, Pengfei, et al.
Publicado: (2019) -
Treatment of Synchronous Liver Metastases from Gastric Cancer: A Single-Center Study
por: Yu, Pengfei, et al.
Publicado: (2020) -
Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study
por: Yu, Pengfei, et al.
Publicado: (2023) -
Prediction of Peritoneal Cancer Index and Prognosis in Peritoneal Metastasis of Gastric Cancer Using NLR-PLR-DDI Score: A Retrospective Study
por: Ye, Zeyao, et al.
Publicado: (2022)